We are pioneering Translation Control Therapeutics, a new class of drugs that specifically control protein translation
Translation Control Discovery Platform
With our technology we can visualize and specifically control the synthesis of target proteins, enabling a new strategy against many severe diseases
Translation Control Lab
Anima’s Translation Control Lab (TCL) is purpose-built for the discovery of translation modulators by integrating our proprietary technologies in biology, bioinformatics, big data image analysis and cloud software architecture
• Analysis Assessment
• Bio Data Analysis
Our pipeline programs are in Fibrosis (Collagen type I translation inhibitors), RSV (inhibiting the production of viral proteins by host cell ribosomes), Oncology (C-Myc translation inhibitors) and Huntington’s Disease (monitoring mutant Huntingtin translation pausing).
17 Scientific Collaborations
Eur J Cell Biol (2018) ; 97 : 168-179.
Integr Biol (2016); 8 :645-53
J Cell Biol. 2016; 23;213(4):451-62.
Nucleic Acid Res. (2017); 45 :926-937
News & Events
Live Panel discussion with Yochi Slonim, Anima Biotech CEO
When: July 11th, 2018
Yochi Slonim will participate at the Giant Health Innovators show to discuss leading issues in healthcare tech innovation, talk about case studies illustrating successful tech innovation and implementation, and our vision for a better future where we achieve improved health outcomes at lower cost.
The panel will take place on July 11th.
2018 BIO International Convention
When: June 4th, 2018 - June 7th, 2018
Where: Boston, USA
Anima Biotech will participate and present at the 2018 BIO International Convention.
The conference is hosted by the Biotechnology Innovation Organization who represents over 1,100 biotech companies, academic institutions, state biotech centers and related organizations across the US and over 30 other nations.
Come and see Anima’s CEO presentation on Monday 4th June.
2018 Biotech Investment showcase
When: May 22nd, 2018 - May 23rd, 2018
Where: London, United Kingdom
Anima Biotech will participate and present at the BIOTECH INVESTMENT SHOWCASE organized by the Oxford Global Conferences Ltd.
The 2018 Biotech Investment showcase is the UK and Europe’s most focused and leading-edge funding, investment and partnering forum in the biotech sector, hosting over 200 attendees.